Interestingly, overexpression of MDM4 in glioma and melanoma mouse models led to enhanced tumorigenesis and blocked the effectiveness of chemotherapies43,44, all suggesting that MDM4 may be oncogenic and lead to chemotherapy resistance in vivo. This evidence concerns the gene MDM4 and central nervous system cancer.